PRECISION OPTICS CORPORATION, INC. Revenue
PRECISION OPTICS CORPORATION, INC. (POCI) reported Revenue of $8.71 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-05-13
- PRECISION OPTICS CORPORATION, INC. revenues for the quarter ending 2026-03-31 was $8.71M, a 108.04% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. revenues for the quarter ending 2025-12-31 was $7.37M, a 62.76% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. revenues for the quarter ending 2025-09-30 was $6.68M, a 59.18% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. revenues for the quarter ending 2025-06-30 was $6.18M, a 31.07% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. revenues for fiscal 2025 was $19.09M, a 0.07% decline from fiscal 2024.
- PRECISION OPTICS CORPORATION, INC. revenues for fiscal 2024 was $19.10M, a 9.22% decline from fiscal 2023.
- PRECISION OPTICS CORPORATION, INC. revenues for fiscal 2023 was $21.04M, a 34.23% increase from fiscal 2022.
- PRECISION OPTICS CORPORATION, INC. revenues for fiscal 2022 was $15.68M, a 46.87% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-03-31 | $8.71M 10-Q · filed 2026-05-13 | $16.08M derived: sum of 2 quarters · filed 2026-05-13 | $22.76M 10-Q · filed 2026-05-13 | $28.94M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | $7.37M 10-Q · filed 2026-02-17 | $14.05M 10-Q · filed 2026-02-17 | $20.23M derived: sum of 3 quarters · filed 2026-02-17 | $24.42M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-09-30 | $6.68M 10-Q · filed 2025-11-13 | $12.86M derived: sum of 2 quarters · filed 2025-11-13 | $17.05M derived: sum of 3 quarters · filed 2026-05-13 | $21.58M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-30 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $10.37M derived: sum of 2 quarters · filed 2026-05-13 | $14.89M derived: sum of 3 quarters · filed 2026-05-13 | $19.09M 10-K · filed 2025-09-29 |
| 2025-03-31 | $4.19M 10-Q · filed 2026-05-13 | $8.71M derived: sum of 2 quarters · filed 2026-05-13 | $12.91M 10-Q · filed 2026-05-13 | $17.63M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $4.53M 10-Q · filed 2026-02-17 | $8.72M 10-Q · filed 2026-02-17 | $13.44M derived: sum of 3 quarters · filed 2026-02-17 | $18.68M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $4.20M 10-Q · filed 2025-11-13 | $8.91M derived: sum of 2 quarters · filed 2025-11-13 | $14.16M derived: sum of 3 quarters · filed 2025-11-13 | $18.98M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $9.96M derived: sum of 2 quarters · filed 2025-09-29 | $14.78M derived: sum of 3 quarters · filed 2025-09-29 | $19.10M 10-K · filed 2025-09-29 |
| 2024-03-31 | $5.24M 10-Q · filed 2025-05-15 | $10.07M derived: sum of 2 quarters · filed 2025-05-15 | $14.39M 10-Q · filed 2025-05-15 | $19.41M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $4.82M 10-Q · filed 2025-02-13 | $9.15M 10-Q · filed 2025-02-13 | $14.17M derived: sum of 3 quarters · filed 2025-02-13 | $19.22M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $4.32M 10-Q · filed 2024-11-14 | $9.35M derived: sum of 2 quarters · filed 2024-11-14 | $14.39M derived: sum of 3 quarters · filed 2024-11-14 | $20.28M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $10.07M derived: sum of 2 quarters · filed 2024-09-30 | $15.96M derived: sum of 3 quarters · filed 2024-09-30 | $21.04M 10-K · filed 2024-09-30 |
| 2023-03-31 | $5.05M 10-Q · filed 2024-05-15 | $10.94M derived: sum of 2 quarters · filed 2024-05-15 | $16.02M 10-Q · filed 2024-05-15 | $20.81M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $5.89M 10-Q · filed 2024-02-14 | $10.97M 10-Q · filed 2024-02-14 | $15.77M derived: sum of 3 quarters · filed 2024-02-14 | $20.42M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | $5.09M 10-Q · filed 2023-11-14 | $9.88M derived: sum of 2 quarters · filed 2023-11-14 | $14.53M derived: sum of 3 quarters · filed 2023-11-14 | $18.43M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $9.44M derived: sum of 2 quarters · filed 2023-09-28 | $13.34M derived: sum of 3 quarters · filed 2023-09-28 | $15.68M 10-K · filed 2023-09-28 |
| 2022-03-31 | $4.65M 10-Q · filed 2023-05-15 | $8.55M derived: sum of 2 quarters · filed 2023-05-15 | $10.88M 10-Q · filed 2023-05-15 | $13.56M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $3.90M 10-Q · filed 2023-02-14 | $6.23M 10-Q · filed 2023-02-14 | $8.91M derived: sum of 3 quarters · filed 2023-02-14 | $11.36M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $2.34M 10-Q · filed 2022-11-14 | $5.01M derived: sum of 2 quarters · filed 2022-11-14 | $7.47M derived: sum of 3 quarters · filed 2022-11-14 | $10.25M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $5.13M derived: sum of 2 quarters · filed 2022-09-27 | $7.92M derived: sum of 3 quarters · filed 2022-09-27 | $10.67M 10-K · filed 2022-09-27 |
| 2021-03-31 | $2.46M 10-Q · filed 2022-05-16 | $5.24M derived: sum of 2 quarters · filed 2022-05-16 | $8.00M 10-Q · filed 2022-05-16 | $10.24M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $2.79M 10-Q · filed 2022-02-14 | $5.54M 10-Q · filed 2022-02-14 | $7.78M derived: sum of 3 quarters · filed 2022-02-14 | $10.15M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-09-30 | $2.76M 10-Q · filed 2021-11-15 | $4.99M derived: sum of 2 quarters · filed 2021-11-15 | $7.37M derived: sum of 3 quarters · filed 2021-11-15 | $10.17M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $4.61M derived: sum of 2 quarters · filed 2021-09-28 | $7.41M derived: sum of 3 quarters · filed 2021-09-28 | $9.92M 10-K · filed 2021-09-28 |
| 2020-03-31 | $2.37M 10-Q · filed 2020-05-14 | $5.17M derived: sum of 2 quarters · filed 2020-05-14 | $7.69M 10-Q · filed 2020-05-14 | $10.07M derived: sum of 4 quarters · filed 2020-09-24 |
| 2019-12-31 | $2.80M 10-Q · filed 2020-02-13 | $5.31M 10-Q · filed 2020-02-13 | $7.69M derived: sum of 3 quarters · filed 2020-09-24 | $9.08M derived: sum of 4 quarters · filed 2020-09-24 |
| 2019-09-30 | $2.51M 10-Q · filed 2019-11-14 | $4.90M derived: sum of 2 quarters · filed 2020-09-24 | $6.28M derived: sum of 3 quarters · filed 2020-09-24 | $7.76M derived: sum of 4 quarters · filed 2020-09-24 |
| 2019-06-30 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-24 | $3.77M derived: sum of 2 quarters · filed 2020-09-24 | $5.24M derived: sum of 3 quarters · filed 2020-09-24 | $6.80M 10-K · filed 2020-09-24 |
| 2019-03-31 | $1.39M 10-Q · filed 2019-05-15 | $2.86M derived: sum of 2 quarters · filed 2020-02-13 | $4.42M 10-Q · filed 2019-05-15 | $5.88M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-12-31 | $1.48M 10-Q · filed 2020-02-13 | $3.04M 10-Q · filed 2020-02-13 | $4.50M derived: sum of 3 quarters · filed 2020-02-13 | $5.23M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-09-30 | $1.56M 10-Q · filed 2019-11-14 | $3.02M derived: sum of 2 quarters · filed 2019-11-14 | $3.76M derived: sum of 3 quarters · filed 2019-11-14 | $4.57M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $2.20M derived: sum of 2 quarters · filed 2019-09-26 | $3.01M derived: sum of 3 quarters · filed 2019-09-26 | $4.04M 10-K · filed 2019-09-26 |
| 2018-03-31 | $735.60K 10-Q · filed 2019-05-15 | $1.55M derived: sum of 2 quarters · filed 2019-05-15 | $2.58M 10-Q · filed 2019-05-15 | $3.30M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $812.77K 10-Q · filed 2019-02-12 | $1.84M 10-Q · filed 2019-02-12 | $2.56M derived: sum of 3 quarters · filed 2019-02-12 | $3.54M derived: sum of 4 quarters · filed 2019-02-12 |
| 2017-09-30 | $1.03M 10-Q · filed 2018-11-14 | $1.75M derived: sum of 2 quarters · filed 2018-11-14 | $2.73M derived: sum of 3 quarters · filed 2018-11-14 | $3.33M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $720.22K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-27 | $1.70M derived: sum of 2 quarters · filed 2018-09-27 | $2.30M derived: sum of 3 quarters · filed 2018-09-27 | $3.15M 10-K · filed 2018-09-27 |
| 2017-03-31 | $983.19K 10-Q · filed 2018-05-15 | $1.58M derived: sum of 2 quarters · filed 2018-05-15 | $2.43M 10-Q · filed 2018-05-15 | $3.40M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $601.59K 10-Q · filed 2018-02-14 | $1.45M 10-Q · filed 2018-02-14 | $2.41M derived: sum of 3 quarters · filed 2018-02-14 | $3.55M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | $849.55K 10-Q · filed 2017-11-14 | $1.81M derived: sum of 2 quarters · filed 2017-11-14 | $2.95M derived: sum of 3 quarters · filed 2017-11-14 | $3.91M derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $962.68K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $2.10M derived: sum of 2 quarters · filed 2017-09-28 | $3.06M derived: sum of 3 quarters · filed 2017-09-28 | $3.92M 10-K · filed 2017-09-28 |
| 2016-03-31 | $1.14M 10-Q · filed 2017-05-15 | $2.10M derived: sum of 2 quarters · filed 2017-05-15 | $2.95M 10-Q · filed 2017-05-15 | $3.92M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $954.77K 10-Q · filed 2017-02-14 | $1.81M 10-Q · filed 2017-02-14 | $2.78M derived: sum of 3 quarters · filed 2017-02-14 | $3.92M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-09-30 | $858.43K 10-Q · filed 2016-11-14 | $1.82M derived: sum of 2 quarters · filed 2016-11-14 | $2.96M derived: sum of 3 quarters · filed 2016-11-14 | $3.94M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $962.91K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $2.10M derived: sum of 2 quarters · filed 2016-09-28 | $3.08M derived: sum of 3 quarters · filed 2016-09-28 | $3.91M 10-K · filed 2016-09-28 |
| 2015-03-31 | $1.14M 10-Q · filed 2016-05-16 | $2.12M derived: sum of 2 quarters · filed 2016-05-16 | $2.95M 10-Q · filed 2016-05-16 | $3.85M derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | $976.55K 10-Q · filed 2016-02-16 | $1.81M 10-Q · filed 2016-02-16 | $2.71M derived: sum of 3 quarters · filed 2016-02-16 | $3.54M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-09-30 | $830.71K 10-Q · filed 2015-11-12 | $1.73M derived: sum of 2 quarters · filed 2015-11-12 | $2.57M derived: sum of 3 quarters · filed 2015-11-12 | $3.57M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $902.59K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13 | $1.74M derived: sum of 2 quarters · filed 2015-10-13 | $2.74M derived: sum of 3 quarters · filed 2015-10-13 | $3.65M 10-K · filed 2015-10-13 |
| 2014-03-31 | $833.45K 10-Q · filed 2015-05-14 | $1.84M derived: sum of 2 quarters · filed 2015-05-14 | $2.75M 10-Q · filed 2015-05-14 | $3.55M derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $1.01M 10-Q · filed 2015-02-17 | $1.92M 10-Q · filed 2015-02-17 | $2.72M derived: sum of 3 quarters · filed 2015-02-17 | $3.37M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-09-30 | $907.43K 10-Q · filed 2014-11-13 | $1.71M derived: sum of 2 quarters · filed 2014-11-13 | $2.37M derived: sum of 3 quarters · filed 2014-11-13 | $2.86M derived: sum of 4 quarters · filed 2014-11-13 |
| 2013-06-30 | $802.34K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $1.46M derived: sum of 2 quarters · filed 2014-09-29 | $1.96M derived: sum of 3 quarters · filed 2014-09-29 | $2.52M 10-K · filed 2014-09-29 |
| 2013-03-31 | $655.34K 10-Q · filed 2014-05-15 | $1.15M derived: sum of 2 quarters · filed 2014-05-15 | $1.72M 10-Q · filed 2014-05-15 | $2.49M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $498.67K 10-Q · filed 2014-02-14 | $1.06M 10-Q · filed 2014-02-14 | $1.83M derived: sum of 3 quarters · filed 2014-02-14 | $2.22M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-09-30 | $563.40K 10-Q · filed 2013-11-14 | $1.34M derived: sum of 2 quarters · filed 2013-11-14 | $1.72M derived: sum of 3 quarters · filed 2013-11-14 | $2.21M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $771.61K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30 | $1.15M derived: sum of 2 quarters · filed 2013-09-30 | $1.65M derived: sum of 3 quarters · filed 2013-09-30 | $2.15M 10-K · filed 2013-09-30 |
| 2012-03-31 | $382.26K 10-Q · filed 2013-05-15 | $876.04K derived: sum of 2 quarters · filed 2013-05-15 | $1.38M 10-Q · filed 2013-05-15 | $2.01M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $493.77K 10-Q/A · filed 2013-02-15 | $998.52K 10-Q/A · filed 2013-02-15 | $1.63M derived: sum of 3 quarters · filed 2013-02-15 | $2.12M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-09-30 | $504.75K 10-Q · filed 2012-11-14 | $1.13M derived: sum of 2 quarters · filed 2012-11-14 | $1.63M derived: sum of 3 quarters · filed 2012-11-14 | $2.07M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $630.04K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $1.13M derived: sum of 2 quarters · filed 2012-10-26 | $1.56M derived: sum of 3 quarters · filed 2012-10-26 | $2.25M 10-K/A · filed 2012-10-26 |
| 2011-03-31 | $495.42K 10-Q · filed 2012-05-15 | $931.19K derived: sum of 2 quarters · filed 2012-05-15 | $1.62M 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $435.77K 10-Q · filed 2012-02-14 | $1.12M 10-Q · filed 2012-02-14 | ||
| 2010-09-30 | $683.90K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |